Montana biologics regulations.

Who may administer PRP, exosomes and stem cells in Montana, and which agencies to check.

A physician at a desk reading regulatory documents

Who may administer biologics in Montana?

In Montana, only licensed healthcare providers, such as medical doctors (MDs) and doctors of osteopathic medicine (DOs), are legally permitted to administer biologic therapies with additional training in cell therapies for specific treatments. Providers should ensure they hold active licenses through the Montana Board of Medical Examiners and meet any additional training required for administering these advanced therapies.

Official sources

Montana compliance guide.

FDA Compliance

The FDA regulates human cell and tissue-based products (HCT/Ps) under specific guidelines to ensure safety and efficacy. Providers in Montana should refer to the FDA’s HCT/P guidelines and Title 21 CFR Part 1271 for applicable federal regulations.

Montana State Regulations

Montana has specific health department guidelines and regulations that biologics providers must follow. Clinics should review Montana’s health department resources for up-to-date compliance information: Montana Department of Public Health and Human Services. These guidelines address patient safety, provider qualifications, and informed consent, helping clinics align with state requirements.

Provider Qualifications

In Montana, only licensed healthcare providers, such as medical doctors (MDs) and doctors of osteopathic medicine (DOs), are legally permitted to administer biologic therapies with additional training in cell therapies for specific treatments. Providers should ensure they hold active licenses through the Montana Board of Medical Examiners and meet any additional training required for administering these advanced therapies.

Patient Informed Consent

Informed consent is essential when administering biologic therapies. Montana clinics must ensure patients understand the benefits, risks, potential side effects, and experimental nature of certain therapies. The consent form should explicitly state that the biologic treatment may not be FDA-approved for certain uses and should be signed by the patient before any procedures.

Additional Requirements

Pre-Treatment and Post-Treatment Protocols

Establishing standardized protocols for patient preparation, post-treatment care, and follow-ups is vital for patient safety and regulatory compliance. Documenting these protocols can demonstrate adherence to best practices.

Standard Operating Procedures (SOPs)

Montana clinics should develop and maintain written SOPs for biologic procedures, from storage to administration. These should align with federal and state standards to ensure consistency and safety.

Medical Liability Insurance

Medical liability insurance is essential for clinics offering biologic treatments in Montana. Providers should check with their insurers to confirm that coverage includes biologic therapies, especially those involving stem cell use.

Marketing Compliance

Montana clinics must ensure that all marketing materials accurately represent the nature of biologic therapies and avoid unproven claims. Review the FDA’s guidance on marketing compliance for further information.

This guide is a general summary to help clinics understand compliance requirements for biologics in Montana. It is not legal advice. Regulations change; consult legal counsel and the agencies above before acting on it.

Montana: common questions.

Who can administer stem cells, PRP and exosomes in Montana?
In Montana, only licensed healthcare providers, such as medical doctors (MDs) and doctors of osteopathic medicine (DOs), are legally permitted to administer biologic therapies with additional training in cell therapies for specific treatments. Providers should ensure they hold active licenses through the Montana Board of Medical Examiners and meet any additional training required for administering these advanced therapies. This is a general summary, not legal advice. Confirm with the state board.
Are stem cell and exosome therapies FDA-approved in Montana?
FDA rules are federal, so they apply in Montana as everywhere else. Exosome and stem cell therapies are not FDA-approved for therapeutic use, and PRP applications are considered off-label.
Do I need an IRB-approved study to offer biologics in Montana?
Investigational treatment belongs inside a reviewed study with proper informed consent. IRB review is not FDA authorisation: culture-expanded and other more-than-minimally-manipulated cell products generally need an IND before use in people.
How do I start offering biologics in Montana?
Start with the live webinar, then a discovery call and live training. After that we verify your Montana licence, protocol, product sourcing, consent process and advertising before you are listed for patient inquiries.

Practising in Montana? Start with the webinar.

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.